Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Safety and Efficacy in Lipoprotein Lipase-Deficient Subjects After Intramuscular Administration of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein LipaseS447X

NCT01109498 is registered in ClinicalTrials.gov with Amsterdam Molecular Therapeutics as lead sponsor.

NCT NCT01109498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01109498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Safety and Efficacy in Lipoprotein Lipase-Deficient Subjects After Intramuscular Administration of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein LipaseS447X
Lead sponsor
Amsterdam Molecular Therapeutics
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2007
Completion date
June 30, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial lipoprotein lipase deficiency